1i5r: Difference between revisions

Revision as of 10:27, 1 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1i5r.png

Template:STRUCTURE 1i5r

TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEXTYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEX

Template:ABSTRACT PUBMED 12223444

About this StructureAbout this Structure

1I5R is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity., Qiu W, Campbell RL, Gangloff A, Dupuis P, Boivin RP, Tremblay MR, Poirier D, Lin SX, FASEB J. 2002 Nov;16(13):1829-31. Epub 2002 Sep 5. PMID:12223444

Page seeded by OCA on Tue Jul 1 10:27:37 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1i5r.gif|left|200px]]
+{{Seed}}
+[[Image:1i5r.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1i5r|  PDB=1i5r  |  SCENE=  }}
-'''TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEX'''
+===TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEX===
-==Overview==
+<!--
-Human estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD type 1) catalyzes the final step in the synthesis of active estrogens that stimulate the proliferation of breast cancer cells. Based on the initial premise to make use of the binding energies of both the substrate and cofactor sites, and molecular modeling starting from the enzyme structure, several estradiol-adenosine hybrids were designed and synthesized. Among these hybrids, EM-1745 with a linker of 8-CH2 groups is proved to be the best competitive inhibitor with a Ki of 3.0 +/- 0.8 nM. The crystal structure of the EM-1745 enzyme complex at 1.6 A provides evidence at atomic resolution of strong interactions between both the steroid and cofactor moieties and the enzyme molecule, as illustrated by a deltaA-weighted 2Fo-Fc electron density map contoured at 3.0 delta. The substrate entry loop is further stabilized in this complex compared with previous complexes of the enzyme. These results confirm our initial strategy of combining studies of structural biology and enzyme mechanism in the inhibitor design, which may be applied to other steroidogenic enzymes involved in human diseases.
+The line below this paragraph, {{ABSTRACT_PUBMED_12223444}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 12223444 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_12223444}}
 ==About this Structure==
@@ Line 32: / Line 36: @@
 [[Category: Hybrid]]
 [[Category: Inhibitor]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 19:36:38 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul  1 10:27:37 2008''